Skip Nav Destination
Issues
15 August 2015
-
Cover Image
Cover Image
Radiation-induced gastrointestinal toxicity is highly relevant to the treatment of pancreatic cancer with radiation. To determine if pharmacological ascorbate changes the response of the gastrointestinal tract following radiation in a clinically meaningful way, a crypt cell assay was performed. The addition of pharmacological ascorbate partially reversed the decreases in jejunal crypt regeneration in both the 10 Gy and 13 Gy groups of mice, suggesting that ascorbate may protect the gastrointestinal tract from the damaging effects of radiation. For details, see article by Du and colleagues on page 3314. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Priority Report
Clinical Studies
Integrated Systems and Technologies
An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis
Hiroyuki Katayama; Clayton Boldt; Jon J. Ladd; Melissa M. Johnson; Timothy Chao; Michela Capello; Jinfeng Suo; Jianning Mao; JoAnn E. Manson; Ross Prentice; Francisco Esteva; Hong Wang; Mary L. Disis; Samir Hanash
Microenvironment and Immunology
Molecular and Cellular Pathobiology
Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations
Yugo Sawai; Yuzo Kodama; Takahiro Shimizu; Yuji Ota; Takahisa Maruno; Yuji Eso; Akira Kurita; Masahiro Shiokawa; Yoshihisa Tsuji; Norimitsu Uza; Yuko Matsumoto; Toshihiko Masui; Shinji Uemoto; Hiroyuki Marusawa; Tsutomu Chiba
Therapeutics, Targets, and Chemical Biology
Author Choice
Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer
Juan Du; John A. Cieslak, III; Jessemae L. Welsh; Zita A. Sibenaller; Bryan G. Allen; Brett A. Wagner; Amanda L. Kalen; Claire M. Doskey; Robert K. Strother; Anna M. Button; Sarah L. Mott; Brian Smith; Susan Tsai; James Mezhir; Prabhat C. Goswami; Douglas R. Spitz; Garry R. Buettner; Joseph J. Cullen
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance
Mark D. Gurden; Isaac M. Westwood; Amir Faisal; Sébastien Naud; Kwai-Ming J. Cheung; Craig McAndrew; Amy Wood; Jessica Schmitt; Kathy Boxall; Grace Mak; Paul Workman; Rosemary Burke; Swen Hoelder; Julian Blagg; Rob L.M. Van Montfort; Spiros Linardopoulos
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
N.V. Rajeshkumar; Prasanta Dutta; Shinichi Yabuuchi; Roeland F. de Wilde; Gary V. Martinez; Anne Le; Jurre J. Kamphorst; Joshua D. Rabinowitz; Sanjay K. Jain; Manuel Hidalgo; Chi V. Dang; Robert J. Gillies; Anirban Maitra
Author Choice
A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy
Alexander V. Yurkovetskiy; Mao Yin; Natalya Bodyak; Cheri A. Stevenson; Joshua D. Thomas; Charles E. Hammond; LiuLiang Qin; Bangmin Zhu; Dmitry R. Gumerov; Elena Ter-Ovanesyan; Alex Uttard; Timothy B. Lowinger
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling
Anna Hultberg; Virginia Morello; Leander Huyghe; Natalie De Jonge; Christophe Blanchetot; Valérie Hanssens; Gitte De Boeck; Karen Silence; Els Festjens; Raimond Heukers; Benjamin Roux; Fabienne Lamballe; Christophe Ginestier; Emmanuelle Charafe-Jauffret; Flavio Maina; Peter Brouckaert; Michael Saunders; Alain Thibault; Torsten Dreier; Hans de Haard; Paolo Michieli
Tumor and Stem Cell Biology
PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia
Daniela Bräuer-Hartmann; Jens-Uwe Hartmann; Alexander Arthur Wurm; Dennis Gerloff; Christiane Katzerke; Maria Vittoria Verga Falzacappa; Pier Giuseppe Pelicci; Carsten Müller-Tidow; Daniel G. Tenen; Dietger Niederwieser; Gerhard Behre
Advertisement